Cocrystal Prediction of Bexarotene by Graph Convolution Network and Bioavailability Improvement

Bexarotene (BEX) was approved by the FDA in 1999 for the treatment of cutaneous T-cell lymphoma (CTCL). The poor aqueous solubility causes the low bioavailability of the drug and thereby limits the clinical application. In this study, we developed a GCN-based deep learning model (CocrystalGCN) for i...

全面介绍

Saved in:
书目详细资料
Main Authors: Fu Xiao (Author), Yinxiang Cheng (Author), Jian-Rong Wang (Author), Dingyan Wang (Author), Yuanyuan Zhang (Author), Kaixian Chen (Author), Xuefeng Mei (Author), Xiaomin Luo (Author)
格式: 图书
出版: MDPI AG, 2022-10-01T00:00:00Z.
主题:
在线阅读:Connect to this object online.
标签: 添加标签
没有标签, 成为第一个标记此记录!

因特网

Connect to this object online.

3rd Floor Main Library

持有资料详情 3rd Floor Main Library
索引号: A1234.567
复印件 1 可用